RVL Pharmaceuticals plc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$72.8M

89 transactions

Summary

RVL Pharmaceuticals plc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $70.1MSales: $1.6M19 insiders

Date	Insider	Type	Value
2022-08-08	Joint reporting: Avista Capital Partners III GP, L.P.; Orbit Co-Invest III LLC; Avista Healthcare Partners, L.P.; Avista Healthcare Partners GP, Ltd.	Buy	$12.4M
2023-10-19	Joint reporting: Altchem Ltd; Orbit Co-Invest A-1 LLC	Sell	$468K
2023-10-19	Harsaul Foundation	Sell	$468K
2023-10-18	Joint reporting: Altchem Ltd; Orbit Co-Invest A-1 LLC	Sell	$205K
2023-10-18	Harsaul Foundation	Sell	$205K
2023-10-20	Joint reporting: Altchem Ltd; Orbit Co-Invest A-1 LLC	Sell	$143K
2023-10-20	Harsaul Foundation	Sell	$143K
2023-01-24	Schaub James(EVP and COO)	F	$12K
2023-01-24	Klein Christopher(General Counsel & Secretary)	F	$12K
2023-08-10	Lask Alisa	F	$6K
2023-05-18	Schaub James(EVP and COO)	F	$5K
2023-05-18	Klein Christopher(General Counsel & Secretary)	F	$5K
2023-08-15	Joint reporting: Avista Healthcare Partners, L.P.; Avista Healthcare Partners GP, Ltd.	J	—
2023-07-05	Lask Alisa	A	$0
2023-07-05	COWAN GREGORY L	A	$0
2023-07-05	DeBiasi Michael J.	A	$0
2023-01-27	Joint reporting: Avista Capital Partners III GP, L.P.; Orbit Co-Invest III LLC; Avista Healthcare Partners, L.P.; Avista Healthcare Partners GP, Ltd.	J	$0
2023-01-27	Venkataraman Sriram	J	$0
2023-01-27	Burgstahler David F	J	$0
2022-08-10	Lask Alisa	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

RVL Pharmaceuticals plc — Contributions, Lobbying & Contracts | Poliscope